Results 151 to 160 of about 88,713,293 (287)

Tim-3 promotes maternal tolerance [PDF]

Nature Immunology, 2017
openaire   +2 more sources

Immune checkpoint TIM-3 in tumor immunotherapy. [PDF]

Acta Biochim Biophys Sin (Shanghai)
Ma S, Zhu M, Ma C, Li C.
europepmc   +1 more source

Structure‐forward targeting of claudins with synthetic binders

FEBS Letters, EarlyView.
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley   +1 more source

Interview with Tim Rogelstad

, 2016
Tim Rogelstad has been the President of Otter Tail Power Company since 2014, and has worked with the company since 1989. Mr. Rogelstad worked as the Manager of Transmission Planning during the CapX2020 initiative.Rogelstad, Tim; Monti, Marta.
Rogelstad, Tim, Monti, Marta
core  

The expression status and clinical value of TIM-3 in intrahepatic cholangiocarcinoma. [PDF]

BMC Cancer
Yin Z, Li J, Liu L, Zhang L, Zhang W, Ma B.   +5 more
europepmc   +1 more source

Nutrient/TOR signaling controls adipose mitochondrial transcription factor A (TFAM) to regulate organismal growth in Drosophila

FEBS Letters, EarlyView.
Animals must match their growth rate to available nutrients. We show that in Drosophila larvae, the nutrient‐sensing TOR kinase controls growth by regulating levels of TFAM, a key regulator of mitochondrial function, in the adipose tissue. When nutrients are abundant, high TOR activity suppresses TFAM, lowering mitochondrial bioenergetic activity and ...
Shrivani Sriskanthadevan‐Pirahas, Shahoon Khan, Abhishek Sharma, Byoungchun Lee, Savraj S. Grewal   +4 more
wiley   +1 more source

The Signaling Networks of TIM-3, TGF-β, and STING in Glioblastoma. [PDF]

Cells
Ahmady-Nield F, Carnie BMH, Anderson GEC, Achari E, Sharma A, Achuthan AA, Kannourakis G, Luwor RB.   +7 more
europepmc   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

FEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang, Ruslana Romaniuk, Hristo L. Svilenov   +2 more
wiley   +1 more source

[Tim Brennan working with students]

, 1997
Tim Brennan, Public Policy, working with students at computersFrom verso: Tim Brennan Public Policy ...
Ford, Tim
core  

Development and evaluation of a peptide-based radiotracer for targeting TIM-3 in preclinical models. [PDF]

Front Immunol
Bao G, Zhang J, Cui Y, Li D, Lu M, Lu R, Xv D, Wu M, Wang S.   +8 more
europepmc   +1 more source